Filing Details

Accession Number:
0001493152-16-016104
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-21 16:04:40
Reporting Period:
2016-12-19
Filing Date:
2016-12-21
Accepted Time:
2016-12-21 16:04:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1360214 Imprimis Pharmaceuticals Inc. IMMY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242177 Md L Richard Lindstrom C/O Imprimis Pharmaceuticals, Inc.
12264 El Camino Real, Suite 350
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-19 100,000 $1.79 100,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Purchase Warrant Acquisiton 2016-12-19 100,000 $0.13 100,000 $1.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
100,000 2016-06-23 2019-12-23 No 4 P Direct
Footnotes
  1. On December 19, 2016 Dr. Lindstrom entered into a definitive agreement to acquire 100,000 Units of Imprimis Pharmaceuticals, Inc.'s (the "Company"), with each Unit consisting of one share of common stock, and a warrant to purchase one share of the Company's common stock, as part of a private placement by the Company to accredited investors.
  2. The value of the Purchase Warrant included in each Unit is $0.125.